Wells Fargo Raises Kyverna Therapeutics (KYTX) PT to $27 on Confidence in KYV-101 Stiff Person Syndrome Trial Readout

新聞報導於1天前

撰寫摘要中...

您可能也對這些小見聞有興趣

Treasury Yields Extend Drop as Risk Aversion Cements Fed View

Bitcoin is Sinking Back Toward $100,000. Where Does it Go From Here?

Jamie Dimon Wants Everyone in the Office. Is a $3 Billion Building the Answer?

AI Stocks and Gold Might Be a Bubble. The Rest of the Market? Not So Much.

VC legend Ron Conway quits Salesforce Foundation after Benioff’s National Guard comments

Teva Pharmaceutical Receives FDA Approval to Expand UZEDY Indication for Maintenance Treatment of Bipolar I Disorder

Apple's Newest Products Are Here. Can They Help Move the Tech Stock Higher?

Crude Prices Slightly Lower on Dollar Strength and Oversupply Concerns

Japan's top banks to jointly issue stablecoin, Nikkei says

AI Is Making Jobs, Not Taking Them

返回所有小見聞